diazepam and devazepide

diazepam has been researched along with devazepide in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19902 (18.18)18.7374
1990's5 (45.45)18.2507
2000's3 (27.27)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anderson, PS; Bock, MG; Chang, RS; DiPardo, RM; Evans, BE; Freidinger, RM; Lundell, GF; Rittle, KE; Veber, DF; Whitter, WL1
Carrupt, PA; Crivori, P; Cruciani, G; Testa, B1
Axe, FU; Bembenek, SD; Butler, CR; Coles, F; Dunford, PJ; Edwards, JP; Fourie, AM; Grice, CA; Karlsson, L; Lundeen, K; Riley, JP; Savall, BM; Tays, KL; Wei, J; Williams, KN; Xue, X1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Lin, JH; Lin, TH1
Hodgson, OJ; Pullen, RG1
Bonnafous, C; Bueno, L; Martinez, J1
Bickerdike, MJ; Dourish, CT; Fletcher, A; Marsden, CA1
Ballaz, S; Barber, A; Del Río, J; Fortuño, A; García-López, MT; Gómez-Monterrey, I; González-Muñiz, R; Herranz, R; Martin-Martínez, M1
Costall, B; Naylor, RJ1
Harper, EA; Morton, MF; Shankley, NP; Tavares, IA1

Other Studies

11 other study(ies) available for diazepam and devazepide

ArticleYear
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:12

    Topics: Administration, Oral; Animals; Benzodiazepines; Chemical Phenomena; Chemistry; Cholecystokinin; Drug Design; Mice; Receptors, Cholecystokinin; Receptors, GABA-A; Structure-Activity Relationship

1988
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
    Journal of medicinal chemistry, 2000, Jun-01, Volume: 43, Issue:11

    Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity.
    Journal of medicinal chemistry, 2008, Jul-24, Volume: 51, Issue:14

    Topics: Administration, Oral; Animals; Anti-Inflammatory Agents; Catalysis; Dogs; Drug Evaluation, Preclinical; Enzyme Inhibitors; Epoxide Hydrolases; Humans; Magnetic Resonance Spectroscopy; Mice; Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Effects of protein binding and experimental disease states on brain uptake of benzodiazepines in rats.
    The Journal of pharmacology and experimental therapeutics, 1990, Volume: 253, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Blood-Brain Barrier; Brain; Devazepide; Diabetes Mellitus, Experimental; Diazepam; Kidney Diseases; Liver Diseases; Male; Phenylurea Compounds; Protein Binding; Rats; Rats, Inbred Strains; Serum Albumin

1990
Penetration of diazepam and the non-peptide CCK antagonist, L-364,718, into rat brain.
    The Journal of pharmacy and pharmacology, 1987, Volume: 39, Issue:10

    Topics: Animals; Benzodiazepinones; Brain; Cholecystokinin; Devazepide; Diazepam; Male; Rats; Rats, Inbred Strains

1987
Gastrointestinal effects of diazepam-withdrawal are linked to activation of central cholecystokinin-ergic pathways in rats.
    The Journal of pharmacy and pharmacology, 1994, Volume: 46, Issue:10

    Topics: Animals; Benzodiazepinones; Brain; Cholecystokinin; Devazepide; Diazepam; Flumazenil; Gastrointestinal Motility; Gastrointestinal Transit; Male; Phenylurea Compounds; Rats; Rats, Wistar; Receptors, Cholecystokinin; Substance Withdrawal Syndrome

1994
The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze.
    European journal of pharmacology, 1994, Dec-27, Volume: 271, Issue:2-3

    Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Devazepide; Diazepam; Indoles; Male; Maze Learning; Meglumine; Niacinamide; Phenylurea Compounds; Piperazines; Piperidines; Rats; Receptors, Cholecystokinin; Selective Serotonin Reuptake Inhibitors; Zimeldine

1994
Pharmacological evaluation of IQM-95,333, a highly selective CCKA receptor antagonist with anxiolytic-like activity in animal models.
    British journal of pharmacology, 1997, Volume: 121, Issue:4

    Topics: Amylases; Animals; Anorexia; Anti-Anxiety Agents; Benzodiazepinones; Carbamates; Cholecystokinin; Devazepide; Diazepam; Disease Models, Animal; Fenfluramine; Guinea Pigs; Hormone Antagonists; Locomotion; Male; Mice; Phenylurea Compounds; Pyrimidinones; Rats; Rats, Wistar; Receptors, Cholecystokinin; Selective Serotonin Reuptake Inhibitors

1997
The influence of 5-HT2 and 5-HT4 receptor antagonists to modify drug induced disinhibitory effects in the mouse light/dark test.
    British journal of pharmacology, 1997, Volume: 122, Issue:6

    Topics: Animals; Avoidance Learning; Behavior, Animal; Benzodiazepinones; Darkness; Devazepide; Diazepam; Drug Antagonism; Fenclonine; Indoles; Light; Losartan; Male; Meglumine; Mice; Organophosphorus Compounds; Proline; Receptors, Serotonin; Receptors, Serotonin, 5-HT4; Ritanserin; Serotonin Antagonists; Sulfonamides

1997
Pharmacological evidence for putative CCK(1) receptor heterogeneity in human colon smooth muscle.
    British journal of pharmacology, 2002, Volume: 136, Issue:6

    Topics: Aspartic Acid; Binding Sites; Binding, Competitive; Colon; Devazepide; Diazepam; Gallbladder; Humans; Indoleacetic Acids; Kinetics; Membranes; Models, Biological; Muscle, Smooth; Naphthalenesulfonates; Organ Culture Techniques; Organ Specificity; Protease Inhibitors; Radioligand Assay; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; Thiazoles; Time Factors

2002